USING WORLD HEALTH ORGANIZATION RECOMMENDATIONS CONSUMPTION ASSESSMENT OF THE ANTIBIOTICS PURCHASED A SINGLE DISTRIBUTION WITHIN THE GUARANTEED VOLUME OF FREE MEDICAL CARE FOR THE PERIOD 2012-2016
Background. One of the key principles of rational use of antibiotics is high quality and reasonable assessment of their consumption. In this paper we used data on medicines purchased by a Single distributor within the guaranteed volume of free medical care for the period 2012 – 2016 гг, submitted by the Committee of Pharmacy of the Health Ministry of the Republic of Kazakhstan (CP HM RK).
Objectives. Evaluation of the consumption of antiinfectives for systemic use, section J01 - antiinfectives for systemic use purchased under the guaranteed volume of free medical care by a single distributor, using the ATC / DDD methodology recommended by the World Health Organization.
Methods. The article presents the methodological approaches to the quantification of antibacterials for systemic use within the ATC / DDD-methodology.
Results. For the period from 2012 to 2016 the consumption of parenteral antibacterial drugs for systemic use purchased under the guaranteed volume of free medical care decreased by almost 30%. And the oral route of administration antibacterial drugs consumption remained unchanged.
Conclusions. The results of the analysis showed a generally positive trend of a decrease in the consumption of antibacterial drugs for systemic use purchased under the guaranteed volume of free medical care.
Gulzira K. Zhussupova, http://orcid.org/0000-0003-3956-6952,
Saule S. Zhaldybayeva, http://orcid.org/0000-0001-8611-8023,
Dinara B. Utepova, http://orcid.org/0000-0001-5884-5020,
Azhar A. Zhamenkenova, http://orcid.org/0000-0001-6289-9953
Rational Drug use Center of the RSE on REM “Republican Center for Health Development” of the Ministry of Healthcare of the Republic of Kazakhstan
1. Makalkina L.G., Pak L.Ju., Uralov S.K., Metelkina N.N., Gurtskaya G.M. Orsenka ispol'zovaniya lekarstvennykh sredstv v meditsinskoi organizatsii [Drug use assessment in medical organization]. Astana. 2010. URL: http://www.druginfo.kz/index.php/ru/dlya-spetsialistov-v-oblasti-zdravookhraneniya/metodicheskie-posobiya (accessed: 02.02.2017).
2. Ob utverzhdenii pravil obespecheniya lekarstvennymi sredstvami grazhdan Prikaz №766 ot 30.09.2015 g. Ministerstva zdravookhraneniya I sotsial'nogo razvitiya Respubliki Kazakhstan, Informatsionno-pravovaya sistema normativnykh pravovykh aktov Respubliki [About the confirmation of sitizens’ drug supply rules Order №766]. Kazakhstan «Әdіlet». URL: https://tengrinews.kz/zakon/pravitelstvo_respubliki_kazahstan_premer_ministr_rk/zdravoohranenie/id-V... (accessed: 18.03.2017).
3. Vvedenie v issledovanie potrebleniya lekarstvennykh sredstv [Introduction to Drug Utilization Research], Vsemirnaya organizatsiya zdravookhraneniya [World Health Organization]. Norvegiya. 2003. URL: http://extranet.who.int/iris/restricted/bitstream/10665/85319/1/924156234X_rus.pdf(accessed: 14.04.2017).
4. Vozrastayushhaya ugroza razvitiya antimikrobnoi rezistentnosti [The growing threat of development of antimicrobial resistance. Possible measures]. Vozmozhnye mery. Vsemirnaya organizatsiya zdravookhraneniya [World Health Organization]. 2013. URL: http://apps.who.int/iris/bitstream/10665/44812/16/9789244503188_rus.pdf?ua=1 (accessed: 14.04.2017).
5. Galstyan G.M., Klyasova G.A., Katrysh S.A., Zolotovskaya I.K., Galstyan A.G., Gorodeckii V.M. Etiologiya nozokomial'nykh pnevmonii u onkogematologicheskikh bol'nykh v otdelenii reanimatsii I intensivnoi terapii [Etiology of nosocomial pneumonia in oncohematological patients in intensive care unit]. Klinicheskaya mikrobiologiya I antimikrobnaya khimioterapiya [Clinical microbiology and antimicrobial chemotherapy] 2011. Tom 13. №3. URL: http://www.antibiotic.ru/cmac/pdf/cmac.2011.t13.n3.p231.pdf (accessed: 14.04.2017).
6. Ziganshina L.E., Magsumova D.R., Kuchaeva A.V., Pikuza O.I., Gersimov V.B., Javorskij A.N. ATC/DDD – klassifikatsionnaya sistema v farmakoepidemiologicheskikh issledovaniyah. [ATC/DDD classification system in pharmacoepidemiological studies]. Kachestvennaya klinicheskaya praktika [Qualitative clinical practice]. 2004. 1. pp. 28-33. URL: http://www.clinvest.su/articles/GCP_2004_1_6abstract.pdf) (accessed: 14.04.2017).
7. Kozlov R.S. Selektsiya rezistentnykh mikroorganizmov pri ispol'zovanii antimikrobnykh preparatov: kontseptsiya «parallel'nogo ushherba» [Selection of resistant microorganisms using antimicrobials: the concept of "parallel damage"] 2007. URL: http://iacmac.ru/cmac/pdf/cmac.2010.t12.n4.p284.pdf (accessed: 06.12.2016).
8. Mostovoi Yu.M., Demchuk A.V. Penitsilliny I tsefalosporiny kak lidery v potreblenii antibiotikov [Penicillins and cephalosporins as leaders in the consumption of antibiotics]. 2012. URL: http://health-ua.com/pics/pdf/ZU_2012_Respirat_3/22-23.pdf (accessed: 05.12.2016).
9. Strachunskii L.S., Belousov Ju.B., Kozlov S.N. Prakticheskoe rukovodstvo po antiinfektsionnoi khimioterapii [Practical guidance on anti-infectious chemotherapy]. URL: http://www.antibiotic.ru/ab/023-29.shtml (accessed: 05.03.2017).
10. ATC/DDD Index 2017. Norwegian Institute of Public Health of WHO Collaborating Centre for Drug Statistics Methodology. 2016. URL: https://www.whocc.no/atc_ddd_index/ (accessed: 14.04.2017).
11. Introduction to Drug Utilization Research. World Health Organization. Norway. 2003. URL: http://www.who.int/medicines/areas/quality_safety/safety_efficacy/Drug%20utilization%20research.pdf?... (accessed: 14.04.2017).